Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity. A Stanford Medicine-led, ...

Subscribe to our newsletter for the latest sci-tech news updates. The study, published in Nature Genetics, was co-led by Michael Green, Ph.D., professor of Lymphoma/Myeloma, and Linghua Wang, MD, Ph.D ...

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

Stage 2 Hodgkin’s lymphoma is an early stage of this cancer. Healthcare professionals describe Hodgkin’s lymphoma as stage 2 when a person has cancer in two or more lymph node groups, either below or ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy, ...

This may make you think before you ink. A study of people in Sweden found that those who had gotten tattoos were 21% more likely to have subsequently been diagnosed with malignant lymphoma. And the ...

Students at the University of Nebraska-Lincoln have created a pilot program for the Lymphoma Research Foundation they hope will raise awareness about the disease among young adults. They are trying to ...

It’s not unusual for cats to have the occasional upset stomach, but when issues persist, something more serious could be ...

A Stanford Medicine-led, international study of hundreds of samples from patients with Hodgkin lymphoma has shown that levels of tumor DNA circulating in their blood can identify who is responding ...